Reuters logo
BRIEF-Perrigo company has filed an abbreviated new drug application with U.S. FDA for Clindamycin
February 7, 2017 / 1:31 PM / 10 months ago

BRIEF-Perrigo company has filed an abbreviated new drug application with U.S. FDA for Clindamycin

Feb 7 (Reuters) - Perrigo Company Plc

* Has filed an abbreviated new drug application with U.S. Food and Drug Administration for Clindamycin

* Notified Valeant Pharmaceuticals North America, Dow Pharmaceutical Sciences of its ANDA filing

* On February 3, 2017, Valeant filed suit in United States District Court for district of New Jersey alleging patent infringement Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below